TP53 and ovarian carcinoma: To examine the correlation between the stemness features and acquired drug resistance depending on the status of the p53 mutation in ovarian cancer cells, we estimated the stemness-like properties of carR-SKOV3 and -OVCAR3 cells compared to each nonR control group (Fig. 1E, F).